On December 7, 2024, the 2024 Pudong International Talent Port Forum with the theme of "Leading · Wisdom · win-win" was held in Zhangjiang Science Hall, and the forum announced and issued the list of leading talents, elite talents and engineers of Pudong New Area 2024 "Pearl Plan" and the certificate of honor. Dr. Liu Haiyang, CEO of Blitzer Biology, attended as an invited guest and was selected and awarded the title of "Pearl Leading Talent" in Pudong New Area in 2024!
Dr. Liu Haiyang, CEO of BRC Biotechnology, won the title of "Pearl Leading Talent"
As a professional biosafety solution provider, BRC Biotechnology has accumulated a good reputation and social recognition since its establishment with excellent service quality, innovation ability and international competitiveness. The award of the title of "Pearl Leading Talent" in Pudong 2024 not only reflects the recognition of the Pudong New Area government and all sectors of society for BRC's professional strength and leading position in the field of biomedicine, but also highlights its outstanding achievements in promoting the development of the biomedical industry and scientific and technological progress. BRC Biotechnology will take this opportunity to continue adhering to the service concept of efficient delivery, scientific and rigorous, constantly strengthen the core competitiveness, attract and gather outstanding talents with international vision, pioneering spirit and innovative ability, and provide global customers with integrated high-quality biosafety services.
About "Pearl Project"
As an important special policy in the "1+1+N" talent policy system of Shanghai Pudong New Area, the "Pearl Program" relies on national laboratories, high-level research universities, national scientific research institutions and leading scientific and technological enterprises, aiming to attract and cultivate a group of high-level strategic scientific and technological talents who stand at the forefront of international science and technology and lead the independent innovation of science and technology. We will promote research and development of key technologies and build world-class industrial clusters.
BRC Biotechnology focuses on compliance quality and safety testing services for biopharmaceuticals, with over 16,000㎡ of testing service platforms, business offices, and training centers in both Shanghai and Suzhou that meet cGMP+GLP+BSL-2 standards. BRC Biotech strictly adheres to pharmacopoeias and regulations from various countries and has obtained certifications such as EU GMP QP, FDA FEI Number, ISO9001: 2015, BSL-2, CMA, and CNAS, ensuring the authenticity, validity, and data integrity of testing results. Its biopharmaceutical evaluation system meets international quality standards, supporting quality evaluations for biopharmaceutical products such as biopharmaceuticals, cell and gene therapies, nucleic acid drugs, and vaccines. Currently, BRC Biotech has full biosafety testing service capabilities, including in vivo animal experiments, and provides integrated services, refusing further outsourcing. Its stable and controllable quality system can cover all projects and the entire lifecycle of drug biosafety testing. Adhering to the service philosophy of efficient delivery and scientific rigor, Bioray Biotech has established biosafety testing capabilities with independent intellectual property, passed audits from nearly 100 leading biopharmaceutical companies at home and abroad, and successfully submitted multiple China-US IND and BLA projects. As your partner in biosafety testing for success, we provide customers with high-quality one-stop biosafety testing services to accelerate the registration and listing of innovative biopharmaceutical products.
Shanghai GMP Testing Center: Provides GMP-level biosafety testing. Its GMP and international quality standard-compliant platforms for molecular, immunological, microbiological, viral, and cell testing have successfully supported domestic and international IND/BLA submissions for vaccines, mRNA, antibodies, and cell gene therapy products.
Suzhou GLP Testing Center: Provides GLP-level viral clearance validation services and CNAS animal experiment services, equipped with electron microscopy and other supporting experimental platforms. It has successfully supported nearly a hundred domestic and international application projects and has successfully passed EU GMP/GLP QP audits.
We offer you
⸺ GMP production cell bank establishment and verification
⸺ Drug substance and product testing services
⸺ Customized product testing technical development
⸺ Production process viral clearance validation services
⸺ Product quality compliance technical consultation
